voxzogo 0.4mg
(vosoritide)BioMarin Pharmaceutical Inc.
Usage: VOXZOGO is indicated for increasing linear growth in pediatric patients with achondroplasia who have open epiphyses. Its approval is based on accelerated approval due to improved annualized growth velocity, with continued approval dependent on further confirmation of clinical benefits.